Climate Change Reporting: A way-out to Improve Risk Management-A Study About Listed Pharmaceutical Companies in Bangladesh


Authors : Tanzina Mahboob

Volume/Issue : Volume 10 - 2025, Issue 5 - May


Google Scholar : https://tinyurl.com/4d2k8vup

DOI : https://doi.org/10.38124/ijisrt/25may1352

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : This study investigates the current state of climate change reporting, emphasizing its potential as a strategic tool to enhance risk management practices among publicly listed pharmaceutical companies in Bangladesh. In response to mounting stakeholder demands for transparency, it is clear that current climate-related disclosures in annual reports are both inconsistent and inadequate. Using a self-constructed disclosure index based on existing literature and global reporting frameworks, the study analyzed secondary data from the annual reports of 18 pharmaceutical firms listed on the Dhaka Stock Exchange. The results indicate that although some companies are beginning to address issues such as emissions and energy use, the majority still fall short in providing comprehensive information. Alarmingly, only 50% of the firms disclosed specific challenges related to climate change, and a mere 17% furnished detailed insights into board-level oversight or future strategies. These findings underscore an urgent need for robust regulatory guidelines, standardized reporting frameworks, and targeted capacity-building initiatives to improve climate disclosures. As Bangladesh seeks to solidify its position in the global pharmaceutical market, embracing climate-conscious business practices is not just essential but imperative for ensuring long-term competitiveness, building investor confidence, and advancing environmental stewardship.

Keywords : Climate Change and its Reporting, Pharmaceutical Industry Risk Management, Annual Report, Dhaka Stock Exchange.

References :

  1. Ahmad, N. N., & Haraf, A. S. (2013). Environmental disclosures of Malaysian property development companies: towards legitimacy or accountability? Social Responsibility Journal.
  2. Ahmed, n. n., & Hossain, D. M. (2015). Climate Change and Global Warming Discourses and Disclosures in the Corporate Annual Reports: A Study on the Malaysian Companies. Procedia - Social and Behavioral Sciences 172.
  3. Azim, M. I., & Azam, S. (2013). CORPORATE SUSTAINABILITY REPORTING BY PHARMACEUTICAL COMPANIES: IS IT WHAT IT SEEMS TO BE? VIRTUS INTERPRESS.
  4. Chowdhury, M., & Alam, Z. (2021). Factors Affecting Access to Finance of Small and Medium Enterprises of Bangladesh. Open Access Library Journal.
  5. corporate Finance Institute. (2017). Retrieved from corporatefinanceinstitute.com: https://corporatefinan ceinstitute.com/resources/accounting/annual-report/
  6. Dey, P. K. (2017). Climate Change Disclosures in the Annual Reports: Evidence from Bangladesh. Asian Journal of Finance & Accounting 9(2):88.
  7. Dhaka Stock Exchange PLC. (2025). Retrieved from www.dsebd.org: https://www.dsebd.org/companylis tbyindustry.php?industryno=18
  8. Eccles, R., & Krzus, M. (2019). Implementing the Task Force on Climate-related Financial Disclosures Recommendations: An Assessment of Corporate Readiness. IDEAS.
  9. Islam , R., & Sultana , S. (2024). Supply Chain Management Analysis and Design for a Variety of Economic Scenarios, Including Data and System Administration. Journal of Software Engineering and Applications.
  10. Islam, J. M. (2020). A Review on Corporate Environmental Reporting (CER): An Emerging Issue in the Corporate World. Canadian Journal of Business and Information Studies.
  11. Kolk, A., & Tulder, R. V. (2010). International business, corporate social responsibility and sustainable development. International Business Review.
  12. renata-ltd.com/annualreport. (2023-2024). Retrieved from renata-ltd.com/annualreport: https://renata-ltd.com/annualreport
  13. Salat, A. (2023). Value Relevance of Climate Change Disclosure: An Empirical Study on The Oil & Gas Companies Listed on Toronto Stock Exchange (TSX). International Journal of Science and Business, IJSAB International,vol. 26(1), 82-94.
  14. shil, N. C., & Iqbal, M. (2005). Environmental disclosure – a Bangladesh perspective. Munich Personal RePEc Archive, https://mpra.ub.uni-muenchen.de/id/eprint/7707.
  15. SNECI Group. (n.d.). Retrieved from SNECI Group website: https://www.sneci.com/en/industries/health-pharmaceuticals/#:~:text=Defined%20as%20the%20set%20of,as%20gene%20therapies%20and%20vaccines.
  16. squarepharma annual report . (2023-2024). Retrieved from squarepharma.com.bd: https://www.squarephar ma.com.bd/downloads/Square%20Pharma_AR_24%20dt-24-11-24_compressed_1.pdf
  17. United Nations Climate Action. (n.d.). Retrieved from United Nations: https://www.un.org/en/climatechange /what-is-climate-change
  18. (n.d.). final-status-of-sustainability-reporting-in-bangladesh. www.globalreporting.org.

This study investigates the current state of climate change reporting, emphasizing its potential as a strategic tool to enhance risk management practices among publicly listed pharmaceutical companies in Bangladesh. In response to mounting stakeholder demands for transparency, it is clear that current climate-related disclosures in annual reports are both inconsistent and inadequate. Using a self-constructed disclosure index based on existing literature and global reporting frameworks, the study analyzed secondary data from the annual reports of 18 pharmaceutical firms listed on the Dhaka Stock Exchange. The results indicate that although some companies are beginning to address issues such as emissions and energy use, the majority still fall short in providing comprehensive information. Alarmingly, only 50% of the firms disclosed specific challenges related to climate change, and a mere 17% furnished detailed insights into board-level oversight or future strategies. These findings underscore an urgent need for robust regulatory guidelines, standardized reporting frameworks, and targeted capacity-building initiatives to improve climate disclosures. As Bangladesh seeks to solidify its position in the global pharmaceutical market, embracing climate-conscious business practices is not just essential but imperative for ensuring long-term competitiveness, building investor confidence, and advancing environmental stewardship.

Keywords : Climate Change and its Reporting, Pharmaceutical Industry Risk Management, Annual Report, Dhaka Stock Exchange.

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe